EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives

Mariana Luiza Silva iD, Matteo Mori iD, Stefania Villa iD, Andrea Tresoldi iD, Fiorella Meneghetti iD, Marcelle de Lima Ferreira Bispo iD

Pharmaceuticals · 30.04.2026 · 19 (5) · 707

DOI: 10.3390/ph19050707 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 30.04.2026. Verfasst von Mariana Luiza Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, State University of Londrina, Rodovia Celso Garcia Cid (PR-445), …. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Milan, CNPq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review offers a critical and comprehensive overview of the most promising covalent inhibitors against traditional and emerging enzymatic targets of Mycobacterium tuberculosis (Mtb). Nearly three decades after the World Health Organisation’s (WHO) declaration of tuberculosis (TB) as a global health emergency, Mtb continues to claim millions of lives, remaining among the leading causes of death worldwide. In recent years, several efforts have been devoted to shortening and improving treatment outcomes and to overcoming increasing drug resistance. The aim of our work is to provide a perspective on recent progress in the field of covalent inhibitors of mycobacterial enzymes, highlighting the current landscape and outlining future directions for safer and more effective strategies.

Schlagwörter

Stichwörter der Autor:innen

anti-TB drug discoverycovalent inhibitorsmycobacterial enzymestuberculosis (TB)

Autor:innen und Institutionen

  • Laboratory for Synthesis of Medicinal Molecules (LaSMMed), Department of Chemistry, State University of Londrina, Rodovia Celso Garcia Cid (PR-445), Londrina 86057-970, Brazil.
  • Department of Pharmaceutical Sciences, University of Milan, Via Luigi Mangiagalli 25, 20133 Milano, Italy.

ORCID-Profile: Mariana Luiza Silva, Matteo Mori, Stefania Villa, Andrea Tresoldi, Fiorella Meneghetti, Marcelle de Lima Ferreira Bispo

Förderung

  • University of Milan
  • CNPq

Zitieren

APA

Silva, M. L., Mori, M., Villa, S., Tresoldi, A., Meneghetti, F., & Bispo, M. L. F. (2026). Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives. Pharmaceuticals, 19(5), 707. https://doi.org/10.3390/ph19050707

Vancouver

Silva ML, Mori M, Villa S, Tresoldi A, Meneghetti F, Bispo MLF. Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives. Pharmaceuticals. 2026;19(5):707. doi:10.3390/ph19050707

BibTeX
@article{Silva2026,
  author = {Silva, Mariana Luiza and Mori, Matteo and Villa, Stefania and Tresoldi, Andrea and Meneghetti, Fiorella and Bispo, Marcelle de Lima Ferreira},
  title = {Covalent Inhibitors Targeting Mycobacterial Enzymes: Current Status, Challenges and Future Perspectives},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {5},
  pages = {707},
  doi = {10.3390/ph19050707}
}
Kostenlos starten →